Repare Therapeutics Inc

Repare Therapeutics Inc

RPTX - Insider Information

Get informed when a big investor buys or sells

+ Follow
Market Cap$114.24M
Close$

Compare to Similar Companies

P/E RatioDividendsReturn on EquityPrice-to-SalesDebt-to-Equity
Repare Therapeutics IncRepare Therapeutics Inc-8.4--63%-2.6-

Insider Trades

Loading insider trades…

Congress Trades

Loading congress trades…

Share Statistics

Market cap$114.24 Million
Enterprise Value$41.75 Million
Earnings per Share$-2
Beta0.96
Outstanding Shares42,965,529

Return

Return on Equity-62.71%ROE
Return on Assets-56.96%
Return on Invested Capital-66.34%

Valuation & Multiples

P/E Ratio-8.43P/E Ratio
PEG7.7PEG
Price to Sales-2.65Price to Sales
Price to Book Ratio1.33Price to Book Ratio
Enterprise Value to Revenue-1
Enterprise Value to EBIT-0.55
Enterprise Value to Net Income-1
Total Debt to Enterprise0.01
Debt to Equity0Debt to Equity

Revenue Sources

No data

Last Earnings Call

Report Date
March 2, 2026
EPS Estimate
$-0.29
Consensus analyst estimate
Revenue Estimate
$2.50 M
Consensus analyst estimate

Institutional Put/Call Ratio

Compares institutional put options with call options. At 0.79, the ratio is below 1, so institutions hold more calls than puts.

Put/Call Ratio0.7875▲ 78.75%
Total Calls251,300▲ 132.47%
Total Puts197,900▲ Infinity%

Institutional Ownership

Holdings and activity of institutional investors.

Ownership %58.56%▼ 4.98%
Total Invested$65.42M▲ 36.31%
Investors Holding52▲ 7.00%

About Repare Therapeutics Inc

Repare Therapeutics Insider Information FAQ

In the latest 13F quarter on Stockcircle, 4 top investors reduced or sold among tracked top investors. Changes are based on reported share counts in their quarterly filings, not day-to-day trading.

Form 4 insider trades are added as new filings are imported. Top investor 13F holdings refresh after each quarterly filing cycle. Politician trade disclosures are added when new reports are published on Stockcircle.